The U.S. Department of Justice has formally accused Done Global of unlawfully distributing ADHD medications without medical need, using a subscription program and targeted advertising to find patients searching for drugs. The company is also accused of filing false medical claims to Medicare, Medicaid and commercial insurance. Done's founder and CEO was convicted last month on related charges and awaits sentencing. 

An exclusive report from local NBC affiliate KARE 11 tells the story of Noah Leopold, a man who died after receiving two new hearts. The first deteriorated, and the second one killed him. Now, his family is suing, saying the Mayo Clinic failed to inform them of the risks. The nonprofit health system denies the allegations. 

The biggest investor in a nursing home chain can run but not hide from comeuppance for the chain’s alleged role in harms—including deaths—done to hundreds of patients.

PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.

PFA has emerged as the preferred ablation strategy for many electrophysiologists, but some questions do remain about its long-term impact. HRS is developing this new registry to be as user-friendly for clinicians as possible.

Peak AI hype seems to have passed. Sobered by reality, formerly breathless futurists can now get a fair hearing when they calmly state the technology really will transform medicine. 

In total, 22 facilities will benefit from the money, provided by the Statewide Health Care Facility Transformation Program. Projects include cybersecurity upgrades and telehealth implementation, in addition to EHR upgrades.

By signing an executive order, President Donald Trump has shifted marijuana from a Schedule I to a Schedule III controlled substance, opening the door for medical and research uses nationwide.